Kyle A Blum
Overview
Explore the profile of Kyle A Blum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grimm S, Karki M, Blum K, Bertocchio J, He R, Tripathi D, et al.
Clin Cancer Res
. 2025 Jan;
PMID: 39836407
Purpose: Renal medullary carcinoma (RMC) is a highly aggressive malignancy defined by the loss of the SMARCB1 tumor suppressor. It mainly affects young individuals of African descent with sickle cell...
2.
Mehr J, Alla K, Blum K, Green T, Panchapakesan K, Freet D, et al.
Transl Androl Urol
. 2023 Sep;
12(8):1326-1335.
PMID: 37680230
Placement of an inflatable penile prosthesis (IPP) in a transgender patient's neophallus carries unique considerations versus cis-gender IPP placement in mitigating infection, erosion, and overall complication rates. An example of...
3.
Blum K, Silagy A, Knezevic A, Weng S, Wang A, Mano R, et al.
BJU Int
. 2023 Aug;
133(2):169-178.
PMID: 37589200
Objective: To evaluate post-nephrectomy outcomes and predictors of cancer-specific survival (CSS) between patients with localised sarcomatoid renal cell carcinoma (sRCC) and those with Grade 4 RCC (non-sRCC), as most sRCC...
4.
Mehr J, Blum K, Green T, Howell S, Palasi S, Sullivan A, et al.
Transl Androl Urol
. 2023 Jun;
12(5):690-699.
PMID: 37305636
Background: Penile prosthesis surgery (PPS) is a commonly used treatment for erectile dysfunction (ED), either as first-line therapy or in cases refractory to other treatment options. In patients with a...
5.
Conroy L, Slovacek H, Blum K, Canfield S, Mann P
J Urol
. 2023 May;
210(2):253.
PMID: 37194284
No abstract available.
6.
Golkaram M, Kuo F, Gupta S, Carlo M, Salmans M, Vijayaraghavan R, et al.
Genome Med
. 2022 Dec;
14(1):143.
PMID: 36536472
Background: Intratumoral heterogeneity (ITH) is a hallmark of clear cell renal cell carcinoma (ccRCC) that reflects the trajectory of evolution and influences clinical prognosis. Here, we seek to elucidate how...
7.
Conroy L, Slovacek H, Blum K, Canfield S, Mann P
J Urol
. 2022 Nov;
209(3):474-484.
PMID: 36416742
Purpose: Assessing trainees' surgical proficiency is an important aspect of urological surgical training. The current standard is the Urology Milestone Project, initially implemented in 2013. This evaluation is limited in...
8.
Blum K, Mehr J, Green T, Macharia K, Kim D, Westney O, et al.
Int J Impot Res
. 2022 Nov;
36(1):89-93.
PMID: 36357570
The main objective of this study was to assess the IPP complication rates of patients undergoing placement via perineal incision versus more traditional penoscrotal approach in synchronous dual implantation. We...
9.
Rappold P, Vuong L, Leibold J, Chakiryan N, Curry M, Kuo F, et al.
Cancer Discov
. 2022 Jun;
12(10):2308-2329.
PMID: 35758895
Significance: Improved understanding of factors that influence metastatic development in localized ccRCC is greatly needed to aid accurate prediction of disease recurrence, clinical decision-making, and future adjuvant clinical trial design....
10.
Kansler E, Dadi S, Krishna C, Nixon B, Stamatiades E, Liu M, et al.
Nat Immunol
. 2022 Jun;
23(8):1285.
PMID: 35705800
No abstract available.